心導管電氣燒灼術設備的全球市場

Global Cardiac Ablation Devices Market

出版日期: 2023年10月04日 | 出版商:

Frost & Sullivan | 英文 64 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

顛覆性技術推動創新

心律不整的增加和對微創治療的需求不斷增加正在推動心導管電氣燒灼術（CA）市場的成長。此外，與 CA 程序相關的風險較小，這使得它們在世界各地受到青睞。由於 COVID-19 大流行對非緊急（選擇性）醫療干涉措施的限制，2020 年和 2021 年全球對 CA 手術的需求有所下降。從2022年開始，疫情法規將放寬，全球CA程序積壓將導致CA設備市場成長激增。該市場包括CA系統、導管、發生器和其他產品領域。

CA 設備市場的參與企業已開始大力投資開發技術先進的解決方案，以快速、準確地治療心律不整，同時改善患者的治療效果。隨著與新興企業和技術供應商的合作不斷增加，CA設備市場已經擴大，產品系列包括心律不整診斷中的人工智慧、基於感測器的穿戴式設備、提高準確性的機器人、先進的繪圖系統、靈活的感測器晶片導管等。 .它以其先進的技術和解決方案獲得了巨大的關注。

微創心律不整治療的優惠報銷和保險政策的可用性可能會進一步支持 CA 手術的市場。在CA手術技術中，射頻消融儀佔全球CA市場佔有率的65%以上，但冷凍消融設備因其微創方法而迅速普及。冷凍消融技術的進步和對智慧冷凍消融設備不斷成長的需求正在導致這些創新技術的快速採用，從而在預測期內推動全球 CA 設備市場規模的成長。在亞太地區，基於球囊的冷凍消融和多電極冷凍消融是一些進步，導致更多地採用冷凍消融技術作為首選 CA 手術。

到 2022 年，美國基於導管的 CA 手術數量將超過心臟植入電子設備手術數量。過去年度，心臟 EP 手術在醫療保險中的比例顯著增加，這主要是由基於導管的 CA 手術推動的。近年來，基於心導管的肺靜脈隔離心房顫動治療的 EP 手術率急劇增加。冷凍消融術普及，因為它可用於心臟直視手術和微創手術，並且在多個病例中已被證明是有效和安全的。這一成長是由 CA 程序的有利報銷政策和亞太地區醫療旅遊業的成長所推動的。用於將冷凍消融與藥物療法或射頻消融相結合的混合方法的先進設備開發為患者提供了增強的、個體化的和更安全的治療選擇。

本研究報告分析了全球心導管電氣燒灼術設備市場，並提出了整體市場前景，包括按最終用戶、用途類型、設備類型和市場公司市場佔有率比例。宏觀經濟要素、最新趨勢、收益預測以及下一代 CA 技術和設備以及多個案例研究均已檢驗。研究期間為2021年至2027年，預測期間為2023年至2027年，以2022年為基準年。該研究重點關注顛覆性創新、未滿足的新市場以及不斷增加的心律不整患病，從而提供特定的市場成長機會。

心導管電氣燒灼術設備市場
心導管電氣燒灼術設備市場：依產品類型細分
心導管電氣燒灼術設備市場：依程序細分
主要競爭
成長指標
成長促進因素
成長抑制因素
預測假設
收益預測
收益預測：按產品細分
收益預測：按地區
收益預測分析
預測分析
競爭環境
CA設備市場形勢：依公司分類
CA設備市場形勢：依最終用戶分類

CA治療-比較分析

什麼是心導管電氣燒灼術（CA）？
CA 與抗心律不整藥物 (AAD)/心房顫動藥物的比較
導管消融術和心臟節律器之間的比較？

CA治療-護理連續分析

心房顫動篩檢的主要建議
心導管電氣燒灼術治療 - 治療
為什麼（基於導管的）CA 需要這麼長時間來管理？- 持續護理分析
心導管電氣燒灼術市場－不斷發展的生態系統
案例研究 1 -美國EP 程序趨勢（2013-2020）

市場公司及解決方案列表

公司和產品清單 -心導管電氣燒灼術解決方案
值得關注的心導管電氣燒灼術系統/解決方案的頂級製造商

下一代心導管電氣燒灼術技術和解決方案

心導管電氣燒灼術新技術和技巧
下一代非加熱心導管電氣燒灼術系統 - Arga Medtech 的相干正弦波電穿孔 (CSE) 脈衝場消融 (PFA)
波士頓科學公司的 FARAPULSE(TM) PFA 系統
配備軟性電極頭和接觸力感測器的消融導管 - Abbott 的 TactiFlex(TM)
改良的溫度監測導管 - Johnson & Johnson (JnJ) (Biosense Webster) 的 QDOT MICRO(TM) 導管
脈衝場消融 (PFA) - 下一代心導管電氣燒灼術技術
市場領導為何投資 PFA 技術 - 美敦力 (Medtronic) 的 PulseSelect PFA 系統測試案例研究

成長機會宇宙

成長機會 1：下一代脈衝場消融技術
成長機會2：利用科技進步與人工智慧進行心律不整診斷
成長機會 3：電生理學機器人技術的未來
成長機會4：瞄準亞太地區

下一步

簡介目錄

Product Code: K94A-54

Disruptive Technologies Drive Innovation

Rising incidents of cardiac arrhythmia and the increasing demand for minimally invasive procedures boost the cardiac ablation (CA) market growth. In addition, fewer risks associated with the CA procedure make it a preference, worldwide. Global demand for CA procedures declined in 2020 and 2021 due to the COVID-19 pandemic restrictions on non-emergency (elective) medical interventions. With the lessening of pandemic restrictions from 2022, the worldwide backlog of CA procedures surged the CA device market growth. The market includes product segments of CA systems, catheters, generators, and others.

CA device market participants started investing heavily in technologically advanced solution development to treat cardiac arrhythmias quickly and precisely, with improved patient outcomes. With more collaborations with start-ups and technology providers, the CA device market is witnessing huge traction with advanced technologies and solutions in the product portfolio, such as AI in arrhythmia diagnosis, sensor-based wearables, robotics for enhanced precision, advanced mapping system, and flexible sensor-tip catheters.

The availability of favorable reimbursement and insurance policies for minimally invasive cardiac arrhythmia treatments will further support the market for CA procedures. In CA procedure technology, although RF ablators dominate the global CA market with more than 65% of the market share, cryoablation devices are rapidly gaining adoption due to their minimally invasive approach. Advancements in cryoablation technology and the growing demand for smart cryoablation devices are rapidly leading to the surge in the adoption of these innovative technologies and bolstering the global CA device market size in the forecast period. In APAC, balloon-based cryoablation and multi-electrode cryoablation are some advancements leading to increased adoption of cryoablation technology as a preferred CA procedure.

In 2022, the frequency of catheter-based CA procedures exceeded the number of cardiac implantable electronic device procedures in the US and is expected to surge during the forecast period. Rates of cardiac EP procedures in Medicare have increased considerably over the last decade, majorly driven by catheter-based CA procedures. The ratio of cardiac catheter-based EP procedures for pulmonary vein isolation for treating AFib has witnessed a rapid rise over the last few years. The prevalence of cryoablation for cardiac arrhythmia treatment, as it can be used in both open-heart and minimally invasive procedures, has proven effectiveness and safety in several cases. This growth is bolstered by favorable reimbursement policies for CA procedures and the growth of the medical tourism industry in APAC. Advanced device development for usage in a hybrid approach by combining cryoablation with drug therapy or RF ablation offers patients enhanced, personalized, and safer treatment options.

This study analyzes the global cardiac ablation device market, including the entire market landscape by end-users, application types, device types, and market share percentage by market players. It examines macroeconomic factors, the latest trends, revenue forecasts, and next-generation CA technologies and devices, along with a few case studies. The study period is from 2021 to 2027, and the forecast period is from 2023 to 2027, with 2022 as the base year. The study provides specific market growth opportunities focusing on disruptive innovations, new unaddressed markets, increasing prevalence of cardiac arrhythmia, and others. The study concludes with the top 4 growth opportunities in the CA device market.

Strategic Imperatives

Why is it Increasingly Difficult to Grow?
The Strategic Imperative 8™
The Impact of the Top 3 Strategic Imperatives on the Global Cardiac Ablation Devices Market
Growth Opportunities Fuel the Growth Pipeline Engine™

Growth Opportunity Analysis

Cardiac Ablation Devices Market
Cardiac Ablation Devices Market Segmentation by Product Types
Cardiac Ablation Devices Market Segmentation by Procedures
Key Competitors
Growth Metrics
Growth Drivers
Growth Restraints
Forecast Assumptions
Revenue Forecast
Revenue Forecast by Product Segments
Revenue Forecast by Region
Revenue Forecast Analysis
Forecast Analysis
Competitive Environment
Landscape of CA Devices Market by Players
CA Devices Market Landscape by End Users

CA Procedure-Comparative Analysis

What is Cardiac Ablation (CA)?
CA vs. Antiarrhythmic Drugs (AAD)/Medication for Atrial Fibrillation
Catheter Ablation vs. Cardiac Pacing?

CA Procedure-Care Continuum Analysis

Key Recommendations for AFib Screening
Cardiac Ablation Therapy-The Procedure
Why (catheter-based) CA Is a Time-consuming Procedure-Care Continuum Analysis
The Cardiac Ablation Market-An Evolving Ecosystem
Case Study 1-Trends in the US EP Procedures (2013-2020)

Market Players and Solutions List

List of Players and Products-Cardiac Ablation Solutions
Top Cardiac Ablation System/solution Manufacturers to Watch

Cardiac Ablation Next-generation Technologies and Solutions

New Cardiac Ablation Technologies and Techniques
Next-gen Non-thermal Cardiac Ablation System-Arga Medtech's Coherent Sine-Burst Electroporation (CSE) Pulsed Field Ablation (PFA)
Boston Scientific's FARAPULSE™ PFA System
Ablation Catheter with Flexible Electrode Tip and Contact Force Sensing-Abbott's TactiFlex™
Catheter with Improved Temperature Monitoring-Johnson & Johnson's (JnJ) (Biosense Webster) QDOT MICRO™ Catheter
Pulsed Field Ablation (PFA)-Next-gen Cardiac Ablation Technique
Why Market Leaders are Investing in PFA Technology-Medtronic PulseSelect PFA System Trial Case Study

Growth Opportunity Universe

Growth Opportunity 1: Next-gen Technology of Pulsed Field Ablation
Growth Opportunity 2: Technological Advancements and AI Use in Cardiac Arrhythmia Diagnosis
Growth Opportunity 3: Future of Robotics in Electrophysiology
Growth Opportunity 4: Target APAC Region